Development of High Throughput Screening Systems for Novel Agents Targeting Thyroid Epithelial Cancers

Part of the Surgical Grand Rounds Series - Jason Prescott, MD, describes the principles and potential translational value of high throughput drug screening and reviews current management of epithelial thyroid cancers, with emphasis on treatment refractory disease.

Created by

Johns Hopkins Greater Washington Area

Related Presenters

Jason Prescott, MD, PhD

Jason Prescott, MD, PhD

Assistant Professor of Surgery

View full profile